尼古丁口香糖市場規模、佔有率、成長分析、按類型、分銷管道、按地區 - 行業預測，2024-2031

Nicotine Gum Market Size, Share, Growth Analysis, By Type (2mg, and 4mg), By Distribution Channel (Supermarkets/hypermarkets, Convenience stores), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月01日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年尼古丁口香糖的全球市場規模為13億美元，從2023年的13.7億美元成長到2031年的21.2億美元，預測期間(2024~2031年)預計複合年成長率為5.6%。

美國尼古丁口香糖市場是 FDA 批准的戒煙輔助劑，由於尋求戒菸的人數顯著增加，預計未來幾年將持續成長。這種口香糖可以與尼古丁貼片一起使用，以緩解戒斷症狀或在需要時對抗強烈的渴望，透過口腔黏膜釋放尼古丁並有效抑制尼古丁衝動。最初受到 COVID-19 封鎖的影響，世界衛生組織 (WHO) 和疾病管制與預防中心 (CDC) 等衛生組織強調了戒菸對於降低與病毒相關的健康風險的重要性。人們越來越意識到吸菸對健康的負面影響，進一步推動了戒菸產品的普及。隨著越來越多的吸菸者意識到與吸菸習慣相關的風險，尼古丁口香糖作為抑制吸菸渴望的美味且易於使用的解決方案的吸引力可能會推動市場成長。消費行為的這些變化，加上持續不斷的倡導戒菸的公共衛生宣傳活動，正在引領尼古丁口香糖產業在競爭激烈的健康市場中持續擴張。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Johnson & Johnson（US）
Novartis AG（Switzerland）
ITC Limited（India）
Cipla Health Limited（India）
Perrigo Company Plc（Ireland）
Teva Canada（Canada）
Philip Morris International Inc.（US）
British American Tobacco PLC（UK）
GlaxoSmithKline plc（UK）
Novartis Consumer Health（Germany）
Fertin Pharma（Denmark）
Alchem International（India）
Revolymer（UK）
Pfizer Inc.（US）
Cambrex Corporation（US）
Reynolds American（US）
Takeda Pharmaceutical Company（Japan）

簡介目錄

Product Code: SQSG35I2048

Global Nicotine Gum Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.37 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 5.6% in the forecast period (2024-2031).

The US nicotine gum market, an FDA-approved smoking cessation aid, is set to experience sustainable growth in the coming years, driven by a notable increase in individuals seeking to quit smoking. This gum, which can be used in conjunction with nicotine patches to alleviate withdrawal symptoms or to combat stronger cravings as needed, releases nicotine through the mouth lining, effectively suppressing the urge for nicotine. Although initially impacted by COVID-19 lockdowns, there has been a resurgence in demand as health organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have emphasized the importance of quitting smoking to mitigate health risks associated with the virus. Rising awareness of the detrimental health effects of smoking has further fueled the push for cessation products. As more smokers recognize the dangers associated with their habits, the appeal of nicotine gum as a flavorful, accessible solution to curb cravings will drive market growth. This shift in consumer behavior, along with ongoing public health campaigns advocating for smoking cessation, positions the nicotine gum sector for sustained expansion in the competitive wellness market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nicotine Gum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nicotine Gum Market Segmental Analysis

Global Nicotine Gum Market is segmented on the basis of type, distribution channel, and region. By type, market is segmented into 2mg, and 4mg. By distribution channel, market is segmented into supermarkets/hypermarkets, convenience stores, pharmacies, and online. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Nicotine Gum Market

The increasing prevalence of diseases linked to tobacco use, such as lung cancer, heart disease, and respiratory ailments, serves as a significant market driver for the global nicotine gum market. As public awareness of the health risks associated with smoking grows, individuals are seeking effective cessation aids to combat their addiction and safeguard their health. Nicotine gum provides a trusted and convenient method for smokers to manage cravings and reduce withdrawal symptoms, thus promoting healthier lifestyles. Consequently, the escalating global tobacco crisis is intensifying the demand for nicotine replacement therapies, positioning nicotine gum as a crucial solution in public health efforts to reduce smoking-related morbidity and mortality.

Restraints in the Global Nicotine Gum Market

The Global Nicotine Gum market faces significant restraints due to the common adverse reactions associated with its use, which include high blood pressure, rapid heart rate, dizziness, insomnia, and gastrointestinal issues such as nausea and indigestion. These side effects can deter potential users from adopting nicotine gum as a smoking cessation aid, as individuals may be hesitant to experience discomfort or health complications. Additionally, the risk of experiencing prolonged adverse effects from frequent chewing can further discourage usage, ultimately suppressing market growth during the forecast period as consumers exercise caution in seeking alternatives for nicotine replacement therapies.

Market Trends of the Global Nicotine Gum Market

The global nicotine gum market is poised for significant growth in the coming years, driven by heightened health awareness and a collective shift towards healthier lifestyles. Increased government focus on reducing smoking rates through comprehensive tobacco control measures-including bans on advertising, promotion, and the gradual escalation of tobacco taxes-will bolster demand for nicotine replacement therapies. These initiatives, combined with efforts to limit smoking in workplaces and public areas, are expected to not only curtail the prevalence of smoking but also encourage smokers to seek alternatives like nicotine gum, ultimately expanding the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree Of Competition
Top Investment Pockets
Ecosystem Of the Market
Value Chain Analysis
Raw Material Analysis
Pricing Analysis
Consumer Behaviour Analysis
PESTLE Analysis

Nicotine Gum Market, By Type

Market Overview
2mg
4mg

Nicotine Gum Market, By Distribution Channel

Market Overview
Supermarkets/hypermarkets
Convenience stores
Pharmacies
Online

Nicotine Gum Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ITC Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Health Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Canada (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philip Morris International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
British American Tobacco PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis Consumer Health (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fertin Pharma (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alchem International (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revolymer (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reynolds American (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments